Cynthia Collins is of MAXCYTE, INC.. Currently has a direct ownership of 51,679 shares of MXCT, which is worth approximately $185,010. The most recent transaction as insider was on Oct 14, 2024, when has been sold 51,679 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.7K
n/a 3M change
n/a 12M change
Total Value Held $185,010

Cynthia Collins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 14 2024
BUY
Grant, award, or other acquisition
-
51,679 Added 50.0%
51,679 Common Stock

Also insider at

EDIT
Editas Medicine, Inc. Healthcare
DMTK
DermTech, Inc. Healthcare
PSTX
Poseida Therapeutics, Inc. Healthcare
CERT
Certara, Inc. Healthcare
CC

Cynthia Collins

Princeton, NJ

Track Institutional and Insider Activities on MXCT

Follow MAXCYTE, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MXCT shares.

Notify only if

Insider Trading

Get notified when an Maxcyte, Inc. insider buys or sells MXCT shares.

Notify only if

News

Receive news related to MAXCYTE, INC.

Track Activities on MXCT